US4570630A
(en)
*
|
1983-08-03 |
1986-02-18 |
Miles Laboratories, Inc. |
Medicament inhalation device
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
GB9216038D0
(en)
*
|
1992-07-28 |
1992-09-09 |
Bespak Plc |
Dispensing apparatus for powdered medicaments
|
AU684754B2
(en)
*
|
1993-03-03 |
1998-01-08 |
Glaxo Wellcome Inc. |
Dry powder inhalator medicament carrier
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
US5505194A
(en)
*
|
1994-03-23 |
1996-04-09 |
Abbott Laboratories |
Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
FR2731911B1
(fr)
*
|
1995-03-20 |
1997-08-14 |
Paul Seyvos |
Dispositif qui permet d'inhaler, par la bouche, l' odeur de produits contenus dans un reservoir a des fins therapeutiques
|
ATE193455T1
(de)
|
1995-12-07 |
2000-06-15 |
Jago Pharma Ag |
Inhalator zur mehrfachen dosisweisen abgabe eines pharmakologischen trockenpulvers
|
US7131441B1
(en)
|
1995-12-07 |
2006-11-07 |
Skyepharma Ag |
Inhaler for multiple dosed administration of a pharmacological dry powder
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
CA2212430A1
(en)
*
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Inhalation device
|
UA73924C2
(en)
*
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
DE29908593U1
(de)
|
1999-05-14 |
1999-07-22 |
Jago Research AG, Hergiswil |
Mundstück für einen Inhalator zur Abgabe eines Medikaments
|
ATE392885T1
(de)
|
2000-02-28 |
2008-05-15 |
Pharmakodex Ltd |
Verabreichungssystemen für oral anzuwendende arzneimittel
|
US6595210B2
(en)
*
|
2000-11-27 |
2003-07-22 |
Unisia Jecs Corporation |
Inhalator for administering powder composition
|
GB2380410B
(en)
*
|
2001-10-05 |
2003-11-19 |
Alchemy Healthcare Ltd |
Apparatus for the nasal or oral delivery of a medicament
|
WO2003078448A1
(en)
|
2002-03-13 |
2003-09-25 |
Signum Biosciences, Inc. |
Modulation of protein methylation and phosphoprotein phosphate
|
ITMO20020297A1
(it)
*
|
2002-10-16 |
2004-04-17 |
Roberto Oliva |
Inalatore per preparati monodose in capsule.
|
US20060045849A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Farhan Taghizadeh |
Method of customizing the fragrance of nasal medications
|
PL370285A1
(pl)
*
|
2004-09-23 |
2006-04-03 |
Glaxosmithkline Pharmaceuticals Spółka Akcyjna |
Inhalator proszkowy
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
US8221804B2
(en)
|
2005-02-03 |
2012-07-17 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
WO2007052154A2
(en)
|
2005-04-29 |
2007-05-10 |
University Of Medicine And Dentistry Of New Jersey |
Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
|
US9345745B2
(en)
|
2005-04-29 |
2016-05-24 |
Bo Wang |
Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
|
US9585932B2
(en)
|
2005-04-29 |
2017-03-07 |
Peter C. Dowling |
Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
|
CA2620123C
(en)
*
|
2005-08-24 |
2011-11-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for treating and monitoring inflammation and redox imbalance in cystic fibrosis
|
US20090192227A1
(en)
*
|
2005-08-24 |
2009-07-30 |
Rabindra Tirouvanziam |
N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
|
US8227408B2
(en)
*
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
GB0604444D0
(en)
|
2006-03-06 |
2006-04-12 |
Optinose As |
Nasal devices
|
CA2689296C
(en)
|
2007-01-10 |
2015-11-17 |
Purdue Research Foundation |
Polypeptide inhibitors of hsp27 kinase and uses therefor
|
WO2009021137A2
(en)
*
|
2007-08-07 |
2009-02-12 |
Purdue Research Foundation |
Kinase inhibitors and uses thereof
|
CA2713762C
(en)
|
2008-02-07 |
2016-10-18 |
University Of Washington |
Circumferential aerosol device
|
WO2009143380A2
(en)
*
|
2008-05-21 |
2009-11-26 |
Neurotez, Inc. |
Methods for treating progressive cognitive disorders related to neurofibrillary tangles
|
KR101629154B1
(ko)
*
|
2008-06-13 |
2016-06-21 |
맨카인드 코포레이션 |
건조 분말 흡입기 및 약물 투여 시스템
|
JP5785085B2
(ja)
*
|
2008-10-20 |
2015-09-24 |
モイライ マトリックス インコーポレイテッド |
癒着を処置又は防止するためのポリペプチド
|
WO2010054017A1
(en)
*
|
2008-11-04 |
2010-05-14 |
Nikolaos Tezapsidis |
Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta
|
BRPI0922448A2
(pt)
*
|
2008-12-10 |
2021-02-17 |
Purdue Research Foundation |
inibidor com base em peptídeo penetrante celular de quinases
|
US8933217B2
(en)
|
2009-07-24 |
2015-01-13 |
Amazentis Sa |
Compounds, compositions, and methods for protecting brain health in neurodegenerative disorders
|
WO2011017132A2
(en)
*
|
2009-07-27 |
2011-02-10 |
Purdue Research, Foundation |
Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
|
RU2612506C2
(ru)
|
2011-03-03 |
2017-03-09 |
Импел Ньюрофарма Инк. |
Устройство для назальной доставки лекарственных средств
|
JP6031510B2
(ja)
|
2011-04-12 |
2016-11-24 |
モイライ マトリックス インコーポレイテッド |
異常な線維芽細胞増殖及び細胞外マトリックスの沈着を特徴とする疾患、症状又はプロセスを予防又は治療する組成物及び方法
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
WO2012148998A1
(en)
|
2011-04-25 |
2012-11-01 |
Cornell University |
Use of uridine and deoxyuridine to treat folate-responsive pathologies
|
RU2741249C2
(ru)
|
2011-05-09 |
2021-01-22 |
Импел Ньюрофарма Инк. |
Наконечники для назальной доставки лекарственных средств
|
EP2589381B1
(en)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions for improving or preserving lung function in a patient with a pulmonary disorder
|
US9452218B2
(en)
|
2012-03-09 |
2016-09-27 |
Purdue Research Foundation |
Compositions and methods for delivery of kinase inhibiting peptides
|
ES2848025T3
(es)
|
2012-09-04 |
2021-08-05 |
Eleison Pharmaceuticals LLC |
Prevención de la recidiva pulmonar del cáncer con cisplatino complejado con lípidos
|
US10537692B2
(en)
|
2013-04-28 |
2020-01-21 |
Impel Neuropharma, Inc. |
Medical unit dose container
|
WO2015006639A1
(en)
|
2013-07-12 |
2015-01-15 |
SILVA, John, H. |
Mouthpiece for inhalers
|
KR101824230B1
(ko)
|
2013-09-10 |
2018-01-31 |
보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 |
절단된 선종성 결장 폴립증 (apc) 단백질을 타겟화하는 치료제
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
USD748242S1
(en)
|
2014-07-11 |
2016-01-26 |
H. Stuart Campbell |
Inhaler mouthpiece
|
US10082496B2
(en)
|
2014-09-10 |
2018-09-25 |
Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
WO2016081475A1
(en)
|
2014-11-17 |
2016-05-26 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
AU2015359043C1
(en)
|
2014-12-10 |
2022-01-06 |
Hyperstem, SA |
Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brian tumors
|
US10087225B2
(en)
|
2015-01-08 |
2018-10-02 |
Moerae Matrix, Inc. |
Formulation of MK2 inhibitor peptides
|
BR112017019343A2
(pt)
|
2015-03-12 |
2018-05-02 |
Moerae Matrix Inc |
uso de composições contendo peptídeo inibidor de mk2 para tratamento de câncer de pulmão de células não pequenas com as mesmas
|
CA2987071A1
(en)
|
2015-06-10 |
2016-12-15 |
Hackensack University Medical Center |
Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
|
US10112948B2
(en)
|
2015-07-06 |
2018-10-30 |
The Board Of Regents Of The University Of Texas System |
Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers
|
DK3322417T3
(da)
|
2015-07-15 |
2023-10-30 |
Univ Texas |
Målretning af emopamil-bindingsprotein (EBP) med små molekyler, der inducerer et unormalt feedbackrespons ved sænkning af endogen cholesterolsyntese
|
CN108601916B
(zh)
|
2015-09-10 |
2021-07-09 |
英倍尔药业股份有限公司 |
直列式鼻部递送装置
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
EP3405175A4
(en)
|
2016-01-20 |
2019-09-25 |
Flurry Powders, LLC |
Encapsulation of Lipophilic Ingredients in Dispersible Aerosol Powder Incorporated Powder
|
EP3713628A4
(en)
|
2017-11-21 |
2021-08-18 |
Impel Neuropharma Inc. |
INTRA-NASAL DEVICE WITH DIVER TUBE
|
CN111372635B
(zh)
|
2017-11-21 |
2022-08-16 |
英倍尔制药公司 |
带有入口接口的鼻内装置
|
WO2019136308A1
(en)
|
2018-01-05 |
2019-07-11 |
Impel Neuropharma, Inc. |
Intranasal delivery of olanzapine by precision olfactory device
|
JP7317020B2
(ja)
|
2018-01-05 |
2023-07-28 |
インペル ファーマシューティカルズ インコーポレイテッド |
精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達
|
JP2021532098A
(ja)
|
2018-07-19 |
2021-11-25 |
インペル ニューロファーマ インコーポレイテッド |
パーキンソン病の治療のためのレボドパおよびドーパデカルボキシラーゼ阻害剤の呼吸管路送達
|
NZ777687A
(en)
|
2019-01-03 |
2023-12-22 |
Impel Pharmaceuticals Inc |
Nasal drug delivery device
|
US11878109B2
(en)
|
2019-05-17 |
2024-01-23 |
Impel Pharmaceuticals Inc. |
Single-use nasal delivery device
|